151 related articles for article (PubMed ID: 37555273)
1. A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer.
Liu S; Kong X; Fang Y; He Z; Wu H; Ji J; Yang X; Ye L; Zhai G
Biomater Sci; 2023 Sep; 11(18):6325-6341. PubMed ID: 37555273
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
3. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
4. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment.
Zhang T; Wang X; Wang D; Lei M; Hu Y; Chen Z; Li Y; Luo Y; Zhang L; Zhu Y
Biomater Adv; 2024 Jun; 160():213859. PubMed ID: 38642515
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
7. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
8. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
9. Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer.
Huang J; Liu X; Lin M; Xiao Z; Shuai X
Biomater Sci; 2024 May; 12(10):2639-2647. PubMed ID: 38563394
[TBL] [Abstract][Full Text] [Related]
10. Novel Carrier-Free Nanodrug Enhances Photodynamic Effects by Blocking the Autophagy Pathway and Synergistically Triggers Immunogenic Cell Death for the Efficient Treatment of Breast Cancer.
Xie L; Wang L; Li L; Liu C; Guo L; Liao Y; Zhou S; Wu W; Duo Y; Shi L; Yuan M
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5683-5695. PubMed ID: 38261396
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
12. Periodic mesoporous organosilica coupled with chlorin e6 and catalase for enhanced photodynamic therapy to treat triple-negative breast cancer.
Tian W; Wang S; Tian Y; Su X; Sun H; Tang Y; Lu G; Liu S; Shi H
J Colloid Interface Sci; 2022 Mar; 610():634-642. PubMed ID: 34838318
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Ca
Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species-sensitive nanophotosensitizers of aminophenyl boronic acid pinacol ester conjugated chitosan-g-methoxy poly(ethylene glycol) copolymer for photodynamic treatment of cancer.
Jeong YI; Kim T; Hwang EJ; Kim SW; Sonntag KC; Kim DH; Koh JW
Biomed Mater; 2020 Aug; 15(5):055034. PubMed ID: 32526727
[TBL] [Abstract][Full Text] [Related]
15. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.
Jin F; Qi J; Liu D; You Y; Shu G; Du Y; Wang J; Xu X; Ying X; Ji J; Du Y
J Control Release; 2021 Sep; 337():90-104. PubMed ID: 34274385
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
[TBL] [Abstract][Full Text] [Related]
17. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
18. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
19. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.
Yoon J; Kim H; Jeong YI; Yang HS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408970
[TBL] [Abstract][Full Text] [Related]
20. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
